Published in J Autoimmune Dis on October 15, 2004
Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J Exp Med (2008) 1.76
Novel autoimmune hepatitis-specific autoantigens identified using protein microarray technology. J Proteome Res (2010) 1.15
The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders. J Autoimmune Dis (2007) 1.02
IgA anti-b2GPI antibodies in patients with autoimmune liver diseases. J Clin Immunol (2008) 0.91
End-organ damage in a mouse model of fulminant liver inflammation requires CD4+ T cell production of IFN-gamma but is independent of Fas. J Immunol (2009) 0.88
Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis. PLoS One (2016) 0.84
Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1. J Clin Immunol (2006) 0.82
Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis. Mol Cell Proteomics (2012) 0.82
Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol (2015) 0.81
Development of a spontaneous liver disease resembling autoimmune hepatitis in mice lacking tyro3, axl and mer receptor tyrosine kinases. PLoS One (2013) 0.80
Two of Them Do It Better: Novel Serum Biomarkers Improve Autoimmune Hepatitis Diagnosis. PLoS One (2015) 0.79
Autoimmune hepatitis as a unique form of an autoimmune liver disease: immunological aspects and clinical overview. Autoimmune Dis (2012) 0.79
Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis. Auto Immun Highlights (2013) 0.78
Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis. J Autoimmune Dis (2007) 0.78
Historical reflections on autoimmune hepatitis. World J Gastroenterol (2008) 0.77
Muscle weakness in a girl with autoimmune hepatitis and Graves' disease. Eur J Pediatr (2008) 0.77
Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions. Gut Liver (2016) 0.77
Autoimmune hepatitis in childhood: the role of genetic and immune factors. World J Gastroenterol (2013) 0.76
The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model. Clin Exp Immunol (2016) 0.75
Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet (1985) 10.67
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med (1988) 8.01
Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology (1994) 7.89
Positional cloning of the APECED gene. Nat Genet (1997) 5.47
An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet (1997) 4.75
Meeting report: International Autoimmune Hepatitis Group. Hepatology (1993) 3.27
Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol (1973) 2.59
Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology (1997) 2.21
Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology (1991) 2.06
Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D. Lancet (1994) 2.05
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet (2000) 2.01
Autoimmune hepatitis in childhood: a 20-year experience. Hepatology (1997) 1.97
Members of the glutathione S-transferase gene family are antigens in autoimmune hepatitis. Gastroenterology (1998) 1.91
High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology (1995) 1.88
Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology (1988) 1.79
Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology (2002) 1.77
Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera. Gastroenterology (1993) 1.71
High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology (1995) 1.70
Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest (1989) 1.61
Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis. J Hepatol (2000) 1.58
Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion. Proc Natl Acad Sci U S A (1992) 1.58
Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol (1998) 1.57
Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II. Proc Natl Acad Sci U S A (1988) 1.57
Cytochrome P450 2A6: a new hepatic autoantigen in patients with chronic hepatitis C virus infection. J Hepatol (2003) 1.53
Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut (2000) 1.53
Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet (1987) 1.43
Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK) J Gastroenterol Hepatol (2000) 1.43
Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology (1993) 1.41
Autoimmune hepatitis: clinical challenges. Gastroenterology (2001) 1.37
LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest (1991) 1.34
Liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology (1992) 1.32
Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology (1988) 1.21
Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Gut (2002) 1.16
Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1. Gastroenterology (1998) 1.14
Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology (1996) 1.13
Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent. Clin Exp Immunol (1983) 1.13
AIRE encodes a nuclear protein co-localizing with cytoskeletal filaments: altered sub-cellular distribution of mutants lacking the PHD zinc fingers. Hum Mol Genet (1999) 1.11
Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc Natl Acad Sci U S A (1987) 1.10
Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis. Clin Exp Immunol (2000) 1.07
Anti-liver-kidney microsome antibody type 1 recognizes human cytochrome P450 db1. Biochem Biophys Res Commun (1989) 1.05
The validity and importance of subtypes in autoimmune hepatitis: a point of view. Am J Gastroenterol (1995) 1.05
Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. Gastroenterology (1999) 1.05
Definition and classification of autoimmune hepatitis. Semin Liver Dis (2002) 1.05
Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis. J Clin Invest (1990) 1.04
Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis. J Hepatol (1999) 1.04
Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis. Hepatology (1996) 1.04
Behavior and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol (1999) 1.02
Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes. Hepatology (1995) 1.02
Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. Gut (1995) 1.02
Non-organ specific autoantibodies in children with chronic hepatitis C. J Hepatol (1996) 1.01
Autoantibodies in liver disease. Gastroenterology (2001) 1.01
Autoantibodies and autoantigens in autoimmune hepatitis. Semin Liver Dis (2002) 1.01
Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure. J Clin Endocrinol Metab (1987) 1.00
Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis. Hepatology (1992) 0.99
Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis. Hepatology (1993) 0.98
A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type-2 (AIH-2) and chronic hepatitis C virus (HCV) infection: a sensitive and quantitative radioligand assay. Clin Exp Immunol (1997) 0.98
Pathogenesis of autoimmune hepatitis. Biomed Pharmacother (1999) 0.97
Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. J Hepatol (1994) 0.96
Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1). Eur J Immunol (1993) 0.96
Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis. Hepatology (1997) 0.96
Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol (2003) 0.95
Aromatic-L-amino-acid decarboxylase, a pyridoxal phosphate-dependent enzyme, is a beta-cell autoantigen. Proc Natl Acad Sci U S A (1995) 0.95
Autoimmune hepatitis. J Hepatol (2000) 0.95
Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins. Hepatology (1998) 0.95
Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis. Am J Gastroenterol (2002) 0.92
Autoimmune polyglandular syndrome type 1. Clin Rev Allergy Immunol (2000) 0.92
Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases. J Hepatol (2000) 0.92
Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection. Clin Exp Immunol (1994) 0.91
Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection. Clin Exp Immunol (2002) 0.91
Autoimmune hepatitis: the investigational and clinical challenges. Hepatology (2000) 0.91
Understanding the pathogenesis of autoimmune hepatitis. Am J Gastroenterol (2001) 0.91
Autoimmune hepatitis in the elderly. Am J Gastroenterol (2001) 0.91
Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Gastroenterology (2001) 0.90
Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of different techniques. J Immunol Methods (1995) 0.90
Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis. Gastroenterology (1996) 0.90
Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece. Eur J Gastroenterol Hepatol (2002) 0.89
Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenterology (1994) 0.89
Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis. Hepatology (1997) 0.89
Hepatitis C and D, retroviruses and autoimmune manifestations. J Autoimmun (2001) 0.89
Autoimmune polyendocrinopathy--candidiasis--ectodermal dystrophy (APECED). Horm Metab Res (1996) 0.89
Patients with type II autoimmune hepatitis express functionally intact cytochrome P-450 db1 that is inhibited by LKM-1 autoantibodies in vitro but not in vivo. Hepatology (1990) 0.89
Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview. Eur J Intern Med (2002) 0.87
Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis. Dig Dis Sci (1996) 0.87
Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment. J Hepatol (1999) 0.87
Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51. Int J Immunopathol Pharmacol (2004) 0.87
Actin is a target antigen of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune hepatitis type-1. J Hepatol (1997) 0.87
Autoimmune regulator AIRE: evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1. Hepatology (2001) 0.86
Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab (1997) 0.86
Cytochrome P450IA2 and aromatic L-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I. FEBS Lett (1997) 0.86
Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis. Hepatology (2001) 0.86
Autoantibodies against cytochromes P450: role in human diseases. Adv Pharmacol (1994) 0.85
Increased incidence of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti-phospholipid syndrome. Eur J Gastroenterol Hepatol (2000) 0.85
Characterization of liver cytokeratin as a major target antigen of anti-SLA antibodies. J Hepatol (1990) 0.85
Clinical features of 89 patients with autoimmune hepatitis in Nagasaki Prefecture, Japan. J Gastroenterol (1999) 0.85
Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection. Gastroenterology (1995) 0.85
Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule. J Immunol (2002) 0.84
Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology (2008) 6.35
Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med (2011) 2.72
Occult hepatitis B virus infection in patients with autoimmune liver diseases. Liver Int (2008) 1.76
Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients. J Hepatol (2011) 1.56
Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2 β-lactamase. Int J Antimicrob Agents (2012) 1.16
Adipokines as mediators of endothelial function and atherosclerosis. Atherosclerosis (2013) 1.16
Alpha-actinin: a multidisciplinary protein with important role in B-cell driven autoimmunity. Autoimmun Rev (2011) 1.14
PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun (2010) 1.13
Spontaneous spondylodiscitis: presentation, risk factors, diagnosis, management, and outcome. Int J Infect Dis (2008) 1.12
Use of TNFα antagonists in refractory AIH: revealing the unforeseen. J Hepatol (2013) 1.07
Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol (2004) 1.06
Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta. Hepatology (2014) 1.04
The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders. J Autoimmune Dis (2007) 1.02
Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat? Liver Int (2011) 0.99
Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis. Liver Int (2007) 0.96
Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis. Liver Int (2009) 0.96
Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification. BMC Infect Dis (2012) 0.95
Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis. J Clin Immunol (2007) 0.93
Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece. World J Gastroenterol (2010) 0.92
Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis. Turk J Gastroenterol (2012) 0.92
Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases. Clin Immunol (2006) 0.91
IgA anti-b2GPI antibodies in patients with autoimmune liver diseases. J Clin Immunol (2008) 0.91
Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis. Hepatology (2007) 0.90
Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatment. Antivir Ther (2011) 0.89
Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease. Clin Exp Med (2013) 0.88
Unusual cardiovascular complications of brucellosis presenting in two men: two case reports and a review of the literature. J Med Case Rep (2011) 0.88
Safety and efficacy of transcatheter arterial chemoemboliazation in the real-life management of unresectable hepatocellular carcinoma. Hepat Mon (2013) 0.88
Ocular disorders as the prevailing manifestations of antiphospholipid syndrome: a case series. Cases J (2009) 0.87
Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis. Clin Chim Acta (2007) 0.86
Descriptive epidemiology of chronic hepatitis B by using data from a hepatitis registry in Central Greece. Eur J Intern Med (2008) 0.86
Molecular diagnostics of primary biliary cirrhosis. Expert Opin Med Diagn (2008) 0.86
Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C. Am J Gastroenterol (2008) 0.86
Risk factors associated with HCV infection in semi-rural areas of central Greece. Eur J Intern Med (2007) 0.86
Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score? Dig Liver Dis (2010) 0.85
Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis. J Autoimmun (2005) 0.84
Hepatitis B virus reactivation in hepatitis B virus surface antigen negative patients receiving immunosuppression: A hidden threat. World J Hepatol (2013) 0.84
Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease. Autoimmunity (2013) 0.84
Primary biliary cirrhosis and Henoch-Schonlein purpura: report of two cases and review of the literature. Liver Int (2007) 0.83
Entecavir monotherapy for lamivudine-refractory chronic hepatitis B. Expert Rev Anti Infect Ther (2008) 0.82
Hepatitis B re-activation with rituximab therapy: treat the patient not the disease. Liver Int (2011) 0.82
Severe pharyngitis in stockbreeders: an unusual presentation of brucellosis. Occup Med (Lond) (2008) 0.82
Single nucleotide polymorphisms in the interferon-gamma and interleukin-10 genes do not influence chronic hepatitis C severity or T-cell reactivity to hepatitis C virus. Liver Int (2004) 0.82
IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases. Clin Chim Acta (2012) 0.82
Alterations of leptin during IFN-alpha therapy in patients with chronic viral hepatitis. J Hepatol (2006) 0.82
Anti-Helicobacter pylori antibody responses specific for VacA do not trigger primary biliary cirrhosis-specific antimitochondrial antibodies. Eur J Gastroenterol Hepatol (2009) 0.81
Primary biliary cirrhosis presented as peripheral eosinophilia in asymptomatic women with or without elevated alkaline phosphatase. Eur J Gastroenterol Hepatol (2004) 0.80
Anti-mitochondrial antibodies in patients with systemic lupus erythematosus: revealing the unforeseen. Clin Chim Acta (2006) 0.80
Oxidative stress and antioxidant status in patients with autoimmune liver diseases. Redox Rep (2014) 0.80
Reactivation of resolved hepatitis B virus infection after immunosuppression: is it time to adopt pre-emptive therapy? Clin Res Hepatol Gastroenterol (2011) 0.80
Leptin receptor isoforms mRNA expression in peripheral blood mononuclear cells from patients with chronic viral hepatitis. Exp Biol Med (Maywood) (2006) 0.79
Development of antimitochondrial antibodies in patients with autoimmune hepatitis: art of facts or an artifact? J Gastroenterol Hepatol (2007) 0.79
Prevalence of gastric parietal cell antibodies and intrinsic factor antibodies in primary biliary cirrhosis. Clin Chim Acta (2009) 0.79
An immunocompetent patient presenting with severe septic arthritis due to Ralstonia pickettii identified by molecular-based assays: a case report. Cases J (2009) 0.79
Unexplained choroidal embolisation: remember the antiphospholipid syndrome. Lancet (2006) 0.78
On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients. Liver Int (2014) 0.78
Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis. J Autoimmune Dis (2007) 0.78
Can mathematical models be useful in clinical hepatology? Liver Int (2010) 0.77
Metabolic acidosis during treatment of mushroom poisoning: a diagnostic pitfall. Intern Med (2012) 0.77
Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis. Liver Int (2014) 0.77
Celiac disease-related autoantibodies in end-stage autoimmune liver diseases: what is the message? Liver Int (2008) 0.77
Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients. World J Gastroenterol (2012) 0.77
Autoimmune hepatitis type-2 and Epstein-Barr virus infection in a toddler: art of facts or an artifact? Ann Hepatol (2013) 0.77
Early primary biliary cirrhosis: a new association with erythema nodosum of unknown origin. Gastroenterol Res Pract (2010) 0.75
Reversion of severe hepatopulmonary syndrome in a non cirrhotic patient after corticosteroid treatment for granulomatous hepatitis: a case report and review of the literature. World J Gastroenterol (2006) 0.75
Autoimmune hepatitis: of host and pathogen. Hepatology (2008) 0.75
Redesigning training for internal medicine. Ann Intern Med (2006) 0.75
Polyclonal hypergammaglobulinemia and high smooth-muscle autoantibody titers with specificity against filamentous actin: consider visceral leishmaniasis, not just autoimmune hepatitis. Int J Infect Dis (2008) 0.75
Primary biliary cirrhosis in HBV and HCV patients: Clinical characteristics and outcome. World J Hepatol (2013) 0.75
Favourable outcome of life-threatening infectious-related haemophagocytic syndrome after combination treatment with corticosteroids and intravenous immunoglobulin infusions. Eur J Intern Med (2011) 0.75
Bone marrow findings in patients with autoimmune liver diseases. J Gastroenterol Hepatol (2008) 0.75
Could the 90s be a second childhood period? The case of Henoch-Schonlein purpura. Age Ageing (2008) 0.75